MicroRNA ‐15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductal adenocarcinoma
Physiological Reports · 2026-07 · 14 (14)
DOI: 10.14814/phy2.71015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, online erschienen am 16.07.2026. Verfasst von Patrick J Ryan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Muscle Biology Laboratory, Department of Kinesiology and Sports Management, Texas A&M University, College Station, Texas, USA. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DOD | US Army | MEDCOM | Congressionally Directed Medical Research Programs (CDMRP), Congressionally Directed Medical Research Programs.
Abstract (Originalsprache)
Dysregulated cellular protein metabolism is a key hallmark of pancreatic ductal adenocarcinoma (PDAC). However, much remains to be learned about how this process is regulated in cancerous cells. Here we investigated the role of two co‐transcribed microRNA (miRNA) species, miR‐15a/16, in regulating cellular protein translation, cell growth, metabolic processes, and clinical features in PDAC. Using cultured PDAC models, we show that overexpression of miR‐15a/16 in cancerous cells slows proliferation and attenuates protein synthesis rates. Bioinformatics analysis reveals that these miRNAs target a broad suite of pathophysiological and metabolic pathways, including numerous genes in cancer‐ and protein‐related processes. Finally, using publicly available patient data, we report that miR‐15a/16 expression is lower in PDAC tumors and in patients with pancreatitis than in healthy controls, and that high expression of miR‐15a/16 in tumors is associated with improved survival in patients. Our results indicate that miR‐15a/16 act as regulators of protein metabolism in PDAC, with potential clinical implications for the management of this devastating disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Muscle Biology Laboratory, Department of Kinesiology and Sports Management, Texas A&M University, College Station, Texas, USA.
- Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
ORCID-Profile: James D Fluckey
Förderung
- DOD | US Army | MEDCOM | Congressionally Directed Medical Research Programs (CDMRP)
- Congressionally Directed Medical Research Programs
Zitieren
APA
Ryan, P. J., Guerra, B. C., Nghiem, P. P., Riechman, S. E., Janini-Gomes, M., & Fluckey, J. D. (2026). MicroRNA ‐15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductal adenocarcinoma. Physiological Reports, 14(14). https://doi.org/10.14814/phy2.71015
Vancouver
Ryan PJ, Guerra BC, Nghiem PP, Riechman SE, Janini-Gomes M, Fluckey JD. MicroRNA ‐15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductal adenocarcinoma. Physiological Reports. 2026;14(14). doi:10.14814/phy2.71015
BibTeX
@article{Ryan2026,
author = {Ryan, Patrick J and Guerra, Bethany C and Nghiem, Peter P and Riechman, Steven E and Janini-Gomes, Mariana and Fluckey, James D},
title = {MicroRNA ‐15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductal adenocarcinoma},
journal = {Physiological Reports},
year = {2026},
volume = {14},
number = {14},
doi = {10.14814/phy2.71015}
}
EUVIMED